E

Eric A. Pierce

Massachusetts Eye and Ear Infirmary

ORCID: 0000-0002-2354-4102

313 papers and 18.3k citations.

PubIndex Score98Top 2%How it's scored

313Publications

18.3kTotal Citations

First publication: 1974First senior author: 1990

Top publicationsby citations

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

Lloyd Paul Aiello, Lois E. H. Smith, Eric A. Pierce et al.|Proceedings of the National Academy of Sciences|1995

Cited by 1.3k

Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

Albert M. Maguire, Jean Bennett, Xiaosong Zhu et al.|The Lancet|2009

Cited by 857

Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration

Francesca Simonelli, Alberto Auricchio, Albert M. Maguire et al.|Molecular Therapy|2009

Cited by 551

AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness

Jean Bennett, Albert M. Maguire, Manzar Ashtari et al.|Science Translational Medicine|2012

Cited by 390

TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum

Nicholas Katsanis, Erica E. Davis, Qi Zhang et al.|Nature Genetics|2011

Cited by 381

Indexing the rest of 313 publications…